Rights and permissions
About this article
Cite this article
Lenograstim + ACE chemotherapy in SCLC improves survival without compromising QOL. Pharmacoecon. Outcomes News 255, 10 (2000). https://doi.org/10.1007/BF03275392
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275392